5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside

ISRG, GMED, EW, ALC and IRMD show strong short-term upside as AI tools, acquisitions and new product pipelines fuel growth.

Zacks Investment Research • Mar 10, 2026

Bears are Losing Control Over Globus Medical (GMED), Here's Why It's a 'Buy' Now

Globus Medical (GMED) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Investment Research • Mar 9, 2026

Why Top-Tier Robotic Surgery Name Globus Medical Is Getting 'Aggressive' In 2026

Globus Medical stock has been a on a hot streak since early November thanks to a resurgence for its robotics division and strong U.S. spine segment.

Investors Business Daily • Mar 6, 2026

Is This the Right Time to Add Globus Medical Stock to Your Portfolio?

GMED gains share in musculoskeletal solutions with spine growth, rapid product launches and strong cash, but macro headwinds and rising costs remain risks.

Zacks Investment Research • Mar 5, 2026

Here's Why Globus Medical (GMED) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Mar 5, 2026

Globus Medical (GMED) Upgraded to Strong Buy: What Does It Mean for the Stock?

Globus Medical (GMED) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research • Mar 4, 2026

New Strong Buy Stocks for March 4th

ORN, LRCX, GMED, MYRG and CPRX have been added to the Zacks Rank #1 (Strong Buy) List on March 4, 2026.

Zacks Investment Research • Mar 4, 2026

GE Aerospace, Nuclear Play Lead 5 Stocks Near Buy Points

GE stock is among this list of fast-growers that haven't lost momentum.

Investors Business Daily • Feb 28, 2026

Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript

Globus Medical, Inc. (GMED) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 25, 2026

Globus Medical Reports Fourth Quarter and Full Year 2025 Results

AUDUBON, Pa., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2025.

GlobeNewsWire • Feb 24, 2026